Curocell - Crunchbase Company Profile & Funding

Q: Who invested in Curocell?

Curocell has 19 investors including DS Asset Management And RKPSG.

Q: When was the last funding round for Curocell?

Curocell closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Curocell raised to date?

Curocell has raised obfuscated.

Overview

Curocell

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Curocell

CB Rank

30558

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Founded

obfuscation

Private

Venture - Series Unknown

Daejeon, Taejon-jikhalsi, South Korea

51-100

curocellbtx.com/

Biopharma

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Gunsoo Kim: CEO and Co-founder
Past Role: LG Life Sciences, Manager

Details

Legal Name

Curocell Inc.

Also Known As

큐로셀

Operating Status

Active

Company Type

For Profit

Founders

Gunsoo Kim

Predictions & Insights

Growth Insight

See this Growth Insight

Curocell is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

OVIS™ Technology

A technology that enhances immune cells to overcome immune suppression in tumor microenvironments for cancer treatment.

LIMKATO (림카토)

A CAR-T cell therapy product developed for treating blood cancers and other malignancies.

Research & Development

Curocell is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Curocell	9	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
DS Asset Management	—	Venture Round - Curocell	—
DS Asset Management	—	Venture Round - Curocell	—
DS Asset Management	—	Venture Round - Curocell	—
DS Asset Management	—	Venture Round - Curocell	—
DS Asset Management	—	Venture Round - Curocell	—

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation
obfuscated obfuscation	Nobo Medicine	—	Series C - Nobo Medicine	obfuscated obfuscation